WallStreetZen

NASDAQ: MRNA
Moderna Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MRNA

Based on 11 analysts offering 12 month price targets for Moderna Inc.
Min Forecast
$80.00-77.38%
Avg Forecast
$187.36-47.01%
Max Forecast
$250.00-29.3%

Should I buy or sell MRNA stock?

Based on 13 analysts offering ratings for Moderna Inc.
Buy
Strong Buy
4 analysts 30.77%
Buy
1 analysts 7.69%
Hold
6 analysts 46.15%
Sell
2 analysts 15.38%
Strong Sell
0 analysts 0%

MRNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Argus Research
Top 12%
89
Strong BuyMaintains$230.00-34.95%2021-06-24
Chardan Capital
Top 9%
92
Strong BuyMaintains$188.00-46.83%2021-05-07
Goldman Sachs
Top 10%
91
Strong BuyMaintains$228.00-35.52%2021-05-07
Piper Sandler
Top 20%
81
Strong BuyReiterates$234.00-33.82%2021-04-15
Oppenheimer
Bottom 18%
18
BuyMaintains$206.00-41.74%2021-02-01
Jefferies
Top 10%
91
HoldMaintains$250.00-29.30%2021-07-15
Anonymous
Morgan Stanley
HoldMaintains$190.00-46.27%2021-05-07
Morgan Stanley
Top 17%
84
HoldMaintains$201.00-43.16%2021-02-26
Wells Fargo
Top 33%
68
HoldMaintains$145.00-58.99%2021-02-01
Needham
Top 23%
78
HoldDowngradesN/AN/A2020-12-09

1 of 2

Forecast return on equity

Is MRNA forecast to generate an efficient return?
Company
-18.47%
Industry
9.04%
Market
59.33%
MRNA's Return on Equity is forecast to be low in 3 years (-18.47%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is MRNA forecast to generate an efficient return on assets?
Company
-5.58%
Industry
4.24%
Market
15.31%
MRNA is forecast to generate lower Return on Assets (-5.58%) than the US Biotechnology industry average (4.24%)
Forecast

MRNA earnings per share forecast

What is MRNA's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$25.60+1,665.74%
Avg 2 year Forecast
$17.70+1,120.69%
Avg 3 year Forecast
$7.42+411.86%
MRNA's earnings are forecast to grow at an exceptional rate of 77.07% per year
Forecast

MRNA revenue forecast

What is MRNA's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$18.4B+573.78%
Avg 2 year Forecast
$15.8B+476.7%
Avg 3 year Forecast
$8.8B+223.82%
MRNA's revenue is forecast to grow at an exceptional rate of 53.49% per year
Forecast

MRNA earnings growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
77.07%
Industry
38.19%
Market
18.21%
MRNA's earnings are forecast to grow faster (77.07% per year) than the US Biotechnology industry average (38.19%)
Forecast
MRNA's earnings are forecast to grow faster (77.07% per year) than the US market average (18.21%)
Forecast
MRNA's earnings are forecast to grow faster (77.07% per year) than the risk-free savings rate (1.2%)
Forecast

MRNA revenue growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
53.49%
Industry
50.82%
Market
13.5%
MRNA's revenues are forecast to grow faster (53.49% per year) than the US Biotechnology industry average (50.82%)
Forecast
MRNA's revenues are forecast to grow faster (53.49% per year) than the US market average (13.5%)
Forecast

Moderna Stock Forecast FAQ

Is Moderna Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NASDAQ: MRNA) stock is to Buy MRNA stock.

Out of 13 analysts, 4 (30.77%) are recommending MRNA as a Strong Buy, 1 (7.69%) are recommending MRNA as a Buy, 6 (46.15%) are recommending MRNA as a Hold, 2 (15.38%) are recommending MRNA as a Sell, and 0 (0%) are recommending MRNA as a Strong Sell.

What is MRNA's earnings growth forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's forecast annual earnings growth rate of 77.07% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 38.19%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.21%.

Moderna's earnings in 2021 is $598,166,000.On average, 9 Wall Street analysts forecast MRNA's earnings for 2021 to be $10,280,436,440, with the lowest MRNA earnings forecast at $6,970,522,417, and the highest MRNA earnings forecast at $12,800,705,913. On average, 9 Wall Street analysts forecast MRNA's earnings for 2022 to be $7,107,041,865, with the lowest MRNA earnings forecast at $3,192,145,923, and the highest MRNA earnings forecast at $10,238,958,620.

In 2023, MRNA is forecast to generate $2,980,139,250 in earnings, with the lowest earnings forecast at $-1,826,951,440 and the highest earnings forecast at $6,400,352,957.

What is MRNA's revenue growth forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's forecast annual revenue growth rate of 53.49% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 50.82%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 13.5%.

Moderna's revenue in 2021 is $2,732,006,000.On average, 8 Wall Street analysts forecast MRNA's revenue for 2021 to be $7,391,256,083,243, with the lowest MRNA revenue forecast at $5,423,801,236,311, and the highest MRNA revenue forecast at $9,064,108,385,275. On average, 8 Wall Street analysts forecast MRNA's revenue for 2022 to be $6,326,267,867,367, with the lowest MRNA revenue forecast at $4,473,581,708,365, and the highest MRNA revenue forecast at $9,010,082,821,266.

In 2023, MRNA is forecast to generate $3,552,198,300,113 in revenue, with the lowest revenue forecast at $1,601,292,822,532 and the highest revenue forecast at $5,087,987,485,259.

What is MRNA's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: MRNA) forecast ROA is -5.58%, which is lower than the forecast US Biotechnology industry average of 4.24%.

What is MRNA's Price Target?

According to 11 Wall Street analysts that have issued a 1 year MRNA price target, the average MRNA price target is $187.36, with the highest MRNA stock price forecast at $250.00 and the lowest MRNA stock price forecast at $80.00.

On average, Wall Street analysts predict that Moderna's share price could stay at $187.36 by Jul 15, 2022. The average Moderna stock price prediction forecasts a potential downside of N/A from the current MRNA share price of $353.60.

What is MRNA's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's current Earnings Per Share (EPS) is $1.45. On average, analysts forecast that MRNA's EPS will be $25.60 for 2021, with the lowest EPS forecast at $17.36, and the highest EPS forecast at $31.88. On average, analysts forecast that MRNA's EPS will be $17.70 for 2022, with the lowest EPS forecast at $7.95, and the highest EPS forecast at $25.50. In 2023, MRNA's EPS is forecast to hit $7.42 (min: $-4.55, max: $15.94).

What is MRNA's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: MRNA) forecast ROE is -18.47%, which is considered weak.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.